EQ Equillium, Inc.
NEUTRAL
Impact: 3/10
DEFA14A
Proxy solicitation materials
Latest settled — T+20d
EQ ▲ +10.73% at T+20d
NEUTRAL call ✓ call won +10.73% · α vs SPY +4.69% · entry $2.05 → $2.27
Currently $2.06 · +0.49% from $2.05 entry
T+1d
-3.41%
call -3.41% · α -3.67%
$1.98
settled 5w ago
T+5d
+13.66%
call +13.66% · α +12.02%
$2.33
settled 28d ago
T+20d
+10.73%
call +10.73% · α +4.69%
$2.27
settled 7d ago
T+60d
—
call — · α —
—
in 7w
Price Chart
Loading chart...
Executive Summary
Equillium, Inc. is holding its annual meeting to vote on director elections, a reverse stock split, auditor appointment, and a share count increase. The board recommends voting for all proposals.
Actionable Insight
Monitor voting results and potential implementation of reverse stock split, which could impact share price and trading volume.
Key Facts
- Annual meeting to elect two Class II directors: Charles McDermott and Bruce D. Steel
- Proposal to approve a reverse stock split of common stock at a ratio between 1-for-2 to 1-for-20
- Proposal to increase authorized common shares from 200 million to 400 million
- Proposal to ratify appointment of Crowe LLP as independent auditor
- Board recommends voting FOR all proposals
Financial Impact
Potential reverse stock split and share count increase could impact share price and dilution
shares outstandingdilutionshare price
Risk Factors
- Reverse stock split may not achieve desired effect on share price
- Share count increase could lead to future dilution
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-156100 |
| Document: 0001193125-26-156100-index-headers.html | 0001193125-26-156100 |
| Document: 0001193125-26-156100-index.html | 0001193125-26-156100 |
| Document: 0001193125-26-156100.txt | 0001193125-26-156100 |
5 reports for EQ
Track record builds as more directional reports settle.
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 20, 2026
today
|
Press Release
| $2.06 awaiting T+20 | awaiting T+20 | — | $2.06 (−0.00%) |
|
Apr 17, 2026
4w ago
|
EFFECT
| $2.05 $2.59 | ▲ +26.34% | ▲ +20.97% | $2.06 (+0.49%) |
|
Apr 15, 2026
5w ago
|
DEFA14A
| $2.05 $2.27 | ▲ +10.73% | ▲ +4.69% | $2.06 (+0.49%) |
|
Apr 7, 2026
6w ago
|
S-3
| $1.80 $2.07 | ▲ +15.00% | ▲ +6.46% | $2.06 (+14.44%) |
|
Mar 25, 2026
8w ago
|
Press Release
| $2.06 $2.16 | ▼ −4.85% | ▲ +5.81% | $2.06 (+0.00%) |
Showing 5 of 5
US Market Status
Market Closed — Opens Thu (< 1m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access